Sigma-Aldrich
Fluka & Supelco - Analytical Logo
Decrease Font Size Increase Font Size Email this page to a friend Printer Friendly Page
Solid Phase Extraction

HybridSPE PPT


 
New HybridSPE Precipitation Technology
Ion Suppression & Phospholipid Contamination
Features & Benefits of HybridSPE-PPT
Products
Technical Resources



NEW HybridSPE-Precipitation (HybridSPE-PPT) Technology back to top

HybridSPE-PPT combines the simplicity of protein precipitation with the selectivity of Solid Phase Extraction (SPE) for the targeted removal of phospholipids and proteins in biological plasma/serum (Figure 1). The technology utilizes a patent pending zirconia-coated particle, and exhibits selective affinity towards phospholipids while remaining non-selective towards a range of basic, neutral and acidic compounds. The phospholipid retention mechanism is based on highly selective Lewis acid-base interaction between the proprietary zirconia ions (functionally bonded to the HybridSPE stationary phase) and the phosphate moiety consistent with all phospholipids (Figure 2).

Figure 1. HybridSPE-PPT “In-Well” 96-well Precipitation Method and Phospholipid Removal
hybrid spe ppt

View the details for each step in this process

  1. Precipitate Proteins
  2. Mix
  3. Apply vacuum
  4. Results
 
Figure 2. Lewis Acid-Base Interaction Between Hybrid SPE Zirconia Ions and Phospholipids
Proprietary HybridSPE
Zirconia Coated Silica
zirconium-phosphate interaction The phosphate moiety of phospholipids
Is a strong Lewis base
(electron donor) that interacts with Zr
atoms coated on the silica surface.



Ion-Suppression & Phospholipid Contamination

back to top
In pharmaceutical bioanalysis, researchers develop and run various assays to quantitate drugs, pharmaceutical candidates, and their metabolites in biological fluids such as serum and plasma. As analysts strive for faster analyses, shorter run times, and lower limits of detection, ion-suppression due to inadequate removal endogenous sample interferences has become of great concern. It is well documented that one of the principal causes of ion-suppression is phospholipid contamination. Not only is signal suppression often evident in the positive ion electrospray mode (+ESI), phospholipids can often remain on the analytical column after sample analysis, and elute uncontrollably in a given LC run sequence.




Features & Benefits of HybridSPE-PPT:
back to top
  • Merges both Protein Precipitation (PPT) & Solid Phase Extraction (SPE)
    • Offers simplicity & generic nature of protein precipitation
    • Selectivity approaches SPE via the targeted removal of phospholipids
  • 2-3 step generic procedure
  • 100% removal of phospholipids & precipitated proteins
  • Minimal to no method development
  • Available in 96-well and 1 mL cartridge dimensions
  • Patent pending technology
hybrid spe ppt well plate


Products
back to top
Description Qty Cat. No.
HybridSPE Products
HybridSPE – Precipitation 96-well Plate, 50 mg/well 1 575656-U
HybridSPE – Precipitation Cartridge, 30 mg/1 mL 100 55261-U
Related Products
96-well Protein Precipitation Filter Plate 1 55263-U
Supelco PlatePrep Vacuum Manifold 1 57192-U
96 Square/Deep Well Collection Plates, 0.35 mL, PP 50 575651-U
96 Square/Deep Well Collection Plates, 1 mL, PP 50 575652-U
96 Square/Deep Well Collection Plates, 2 mL, PP 50 575653-U
96 Square Well Pierceable Cap Mats 50 575655-U

Technical Resources back to top
Category / Title Type Size (kb) No. Pages I.D.
Instructions/Data Sheet & Troubleshooting Guide for HybridSPE-PPT Data Sheet 76  T708008
Introducing HybridSPE™-Precipitation Technology for Pharmaceutical Bioanalytical Sample Preparation (Reporter 26.3) Article 389 T208003
HybridSPE-Precipitation Technology Product Information 483  T408102
HybridSPE™–Precipitation Technology - Bridging the Gap between Simplicity and Selectivity in Bioanalytical Sample Prep Presentation 893  58  T408104H
Impact of Ion- Suppression Due to the Presence of Phospholipids on the Enantiomeric LC-MS Analysis of Clenbuterol Presentation 226  T408100H
Selective Depletion of Phospholipid Interference Utilizing Hybrid SPE Technology Presentation 189  T408098H